NASDAQ: SPRY - ARS Pharmaceuticals, Inc.

Yield per half year: +29.53%
Dividend yield: 0.00%
Sector: Healthcare

Share chart ARS Pharmaceuticals, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc., биофармацевтическая компания, разрабатывает методы лечения пациентов и родителей, страдающих тяжелыми аллергическими реакциями. Компания разрабатывает neffy, безыгольный интраназальный назальный спрей с низкой дозой адреналина для пациентов и лиц, осуществляющих уход за ними, с аллергическими реакциями I типа, включая анафилаксию. Компания была основана в 2015 году и базируется в Сан-Диего, штат Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2020-12-04
ISIN US82835W1080
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://ars-pharma.com
Цена ао 11.26
Change price per day: 0% (14.08)
Change price per week: +12.01% (12.57)
Change price per month: +26.28% (11.15)
Change price per 3 month: -6.07% (14.99)
Change price per half year: +29.53% (10.87)
Change price per year: +117.28% (6.48)
Change price per 3 year: +227.44% (4.3)
Change price per 5 year: 0% (14.08)
Change price per 10 year: 0% (14.08)
Change price per year to date: +3.45% (13.61)
All parameters

Underestimation

Title Value Grade
P/S 17551.36 1
P/BV 2.28 6
P/E 0 0
EV/EBITDA -6.76 0
Total: 3.13

Efficiency

Title Value Grade
ROA, % -23.31 0
ROE, % -23.56 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0041 10
Total: 9.4

Growth impulse

Title Value Grade
Yield Revenue, % -99.83 0
Yield Ebitda, % 199.76 10
Yield EPS, % 123.38 10
Total: 8
More

Institutions Volume Share, %
Deerfield Management Company, L.P. (Series C) 11077927 11.69
Orbimed Advisors LLC. 8740887 9.22
FMR, LLC 5088253 5.37
SR One Capital Management, LP 4012903 4.23
Rubric Capital Management LP 3480712 3.67
RA Capital Management, L.P. 3009678 3.18
K2 Principal Fund, L.P. 2686490 2.83
Baker Brothers Advisors, LLC 2006451 2.12
Nextech Invest Ag 1910029 2.02
Vanguard Group Inc 1697637 1.79

ETF Share, % Profitability for 1 year, % Dividends, %
Invesco Dorsey Wright SmallCap Momentum ETF 0.59575 33.91 0.61241
iShares Micro-Cap ETF 0.18438 17.09 1.54048
Invesco Nasdaq Biotechnology ETF 0.13872 28.58 0.8565
Future Tech ETF 0.13757 426.34 0.8416
Principal Healthcare Innovators ETF 0.13757 618.5 0.8416
Direxion Daily S&P Biotech Bull 3x Shares 0.10101 4067.92 0.25924
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.09976 18.2 1.66828
ProShares Ultra Nasdaq Biotechnology 0.09046 51.7 0.85651
Avantis U.S Small Cap Equity ETF 0.0824 27.77 1.68271
Vanguard U.S. Momentum Factor ETF 0.06 30.05 1.05834
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.05874 31.36 1.41955
iShares Russell 2000 Growth ETF 0.05387 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.05 23.05 0.60264
Vanguard Russell 2000 ETF 0.02 17.16 1.48801
Schwab U.S. Small-Cap ETF 0.01776 17.47 1.51433
ProShares UltraPro Russell2000 0.01571 89.82 1.47873
Fidelity MSCI Health Care Index ETF 0.00716 3 1.46057
Humankind US Stock ETF 0.00433 18.81 1.99919
ProShares Hedge Replication ETF 0.00422 5.92 1.47892
iShares Russell 3000 ETF 0.00174 24.83 1.43482
Schwab U.S. Broad Market ETF 0.00128 24.86 1.43354
Avantis U.S. Equity ETF 0.00092 23.04 1.59151
SPDR Portfolio MSCI Global Stock Market ETF 0.00051 17.99 2.19607
Dimensional U.S. Core Equity 2 ETF 0.00029 30.76 1.47098
Dimensional US Core Equity Market ETF 0.00016 30.98 1.40618
Dimensional U.S. Equity ETF 0.00008 31.53 1.3557
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Mr. Richard Lowenthal M.B.A., M.S., MSMSEL Founder, President, CEO & Director 908.83k 1966 (59 years)
Dr. Sarina Tanimoto M.B.A., M.D. Co-Founder & Chief Medical Officer 748.97k 1969 (56 years)
Mr. Eric Karas Chief Commercial Officer 618.61k 1973 (52 years)
Dr. Robert Bell Ph.D. Co-Founder & Chief Science Officer N/A
Ms. Kathleen D. Scott CPA Chief Financial Officer N/A
Mr. Brian T. Dorsey M.S. Chief Operations Officer N/A 1969 (56 years)
Mr. Alexander A. Fitzpatrick Esq. Chief Legal Officer & Secretary N/A 1967 (58 years)
Mr. Daniel Relovsky Senior Vice President of Marketing N/A
Mr. Justin Chakma Chief Business Officer & Secretary N/A 1990 (35 years)
Mr. Harris Kaplan M.B.A. Executive Vice President of Commercial Strategy N/A 1952 (73 years)

Address: United States, San Diego. CA, 11682 El Camino Real - open in Google maps, open in Yandex maps
Website: https://ars-pharma.com